Marshall Wace, LLP Rockwell Medical, Inc. Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 596,359 shares of RMTI stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
596,359
Previous 508,674
17.24%
Holding current value
$1.15 Million
Previous $2.02 Million
39.77%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RMTI
# of Institutions
61Shares Held
8.25MCall Options Held
226KPut Options Held
78.2K-
Armistice Capital, LLC New York, NY3.04MShares$5.84 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.2MShares$2.31 Million0.0% of portfolio
-
Globeflex Capital L P San Diego, CA743KShares$1.43 Million0.13% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny442KShares$849,3120.0% of portfolio
-
Geode Capital Management, LLC Boston, MA320KShares$615,1980.0% of portfolio
About ROCKWELL MEDICAL, INC.
- Ticker RMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 10,675,200
- Market Cap $20.5M
- Description
- Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...